Searchable abstracts of presentations at key conferences in endocrinology

ea0094pl9.1 | Society for Endocrinology Medal Lecture | SFEBES2023

Precision medicine in diabetes: from discovery to implementation

Pearson Ewan

People are all different, and this is no different when we consider people with diabetes, yet the current approaches to management of diabetes tend to treat everyone the same. The field of precision medicine aims to recognise these differences – whether at the level of their phenotype or at the molecular level. Faced with multiple, and increasing, treatment options for diabetes as well as increasing healthcare costs there is a clear need to target therapy to maximise bene...

ea0050p381 | Thyroid | SFEBES2017

Genetic variants modify susceptibility to AF in patients on thyroid hormone replacement therapy

Soto-Pedre Enrique , Siddiqui Moneeza , Doney Alex , Palmer Colin , Pearson Ewan , Leese Graham

Purpose: Hypothyroidism has been associated with atrial fibrillation (AF) in some studies. This study aimed to characterize thyroid related genetic variants that may change susceptibility to AF in patients on thyroid hormone replacement therapy (levothyroxine).Methods: A case-control study was done among patients of European Caucasian ethnicity from the Genetics of Diabetes Audit and Research Tayside (GoDARTS) recruited in Tayside (Scotland...

ea0050p381 | Thyroid | SFEBES2017

Genetic variants modify susceptibility to AF in patients on thyroid hormone replacement therapy

Soto-Pedre Enrique , Siddiqui Moneeza , Doney Alex , Palmer Colin , Pearson Ewan , Leese Graham

Purpose: Hypothyroidism has been associated with atrial fibrillation (AF) in some studies. This study aimed to characterize thyroid related genetic variants that may change susceptibility to AF in patients on thyroid hormone replacement therapy (levothyroxine).Methods: A case-control study was done among patients of European Caucasian ethnicity from the Genetics of Diabetes Audit and Research Tayside (GoDARTS) recruited in Tayside (Scotland...

ea0070oc3.3 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Circulating follistatin predicts type 2 diabetes risk

Wu Chuanyan , Borné Yan , Gao Rui , López Rodriguez Maykel , Roell William , Wilson Jonathan , Ahlqvist Emma , Luan Cheng , Peter Andreas , Machann Jürgen , Hong Mun-Gwan , Schwenk Jochen , Nilsson Peter , Shore Angela , Khan Faisel , Natali Andrea , Melander Olle , Orho-Melander Marju , Nilsson Jan , Renström Erik , Wollheim Claes , Pearson Ewan , Franks Paul , White Morris , Duffin Kevin , Vaag Allan , Laakso Markku , Stefan Norbert , Groop Leif , De Marinis Yang

Follistatin is a hepatokine found to be elevated in patients with type 2 diabetes (T2D) and promotes hyperglycemia in mice. We report that elevated baseline circulating follistatin levels predict future T2D incidence in longitudinal cohorts including up to 5274 individuals. Individuals with elevated circulating follistatin had higher risk of developing type 2 diabetes during follow-up of 4 years (IMI-DIRECT-METSIM, n = 1079, Finland), 5 and 19 years (MDC-CC, n...